Merck’s COVID-19 Pill Appears Effective, but May Pose Pregnancy Risks: FDA
Given safety concerns, FDA scientists said Merck has agreed the drug will not be used in children.
Biden Pushes Vaccines, Masks as Best Defense Against Omicron Variant
News reports out of South Africa noted that COVID-19 cases from omicron have resulted in mostly mild symptoms
Vaccine Makers Already Testing Their Shots Against Omicron Variant
So far, existing vaccines have proven effective against prior coronavirus variants, including the delta variant
Thanksgiving Weekend Brought New COVID-19 Concerns: the Omicron Variant
On Saturday, the CDC issued a statement stressing that 'no cases of this variant have been identified in the U.S. to date'
Caregivers of Childhood Cancer Survivors Concerned About COVID-19 Vaccines
Concerns, expressed early in the rollout, included lack of safety and efficacy data, particularly in children with cancer
Dasatinib Beneficial in Type 2 Diabetes
Patients treated with dasatinib had mean reduction in serum glucose concentration and relative decrease in body weight
Physician’s Briefing Weekly Coronavirus Roundup
CVS Health, Walmart, and Walgreens Played Role in Opioid Crisis: Ohio Jury
Case is the first time the retail side of the drug industry has been held accountable in the U.S. opioid crisis
As Vaccine Deadline Passes, 95 Percent of Federal Workers Have Gotten Shots
Only about 59 percent of the general population are fully vaccinated, according to CDC data
Biden Plan Will Spend $1.5 Billion to Boost Health Worker Supply
The pandemic has exacerbated health care disparities for minorities and underserved communities
